Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement
Holly Lofton, M.D., professor of medicine and surgery at NYU Grossman School of Medicine and the director of the Medical Weight Management Program at NYU Langone Health in New York City
And then, to add to that, when you see states, like Texas and Georgia passing similar bills, which are truly red of the red states, that supposedly are not patient friendly, and dont care about consumers, pass legislation that really prohibit some of the bad activities that PBMs do, it is just mind boggling to me how weve gone to this point
No, shortness of breath is not listed as a common or characteristic side effect in FDA prescribing information for GLP-1 medications